XSpray Pharma AB (STU:6XP) Institutional Ownership: 3.09% (As of Aug. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:6XP XSpray Pharma AB STU:6XP
30 GF Score
Price €0.92
View Full Analysis

What is XSpray Pharma AB Institutional Ownership?

XSpray Pharma AB STU:6XP -2.23% 30 Institutional Ownership is 3.09% as of Aug. 25, 2026. GuruFocus rates STU:6XP with a GF Score™ of 30/100.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, XSpray Pharma AB's institutional ownership is 3.09%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, XSpray Pharma AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, XSpray Pharma AB's Float Percentage Of Total Shares Outstanding is 0.00%.

XSpray Pharma AB Institutional Ownership Historical Data

* Premium members only.

The historical data trend for XSpray Pharma AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

XSpray Pharma AB Institutional Ownership Chart

XSpray Pharma AB Historical Data

The historical data trend for XSpray Pharma AB can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 2.66 3.21 2.46 2.46 2.47 2.59 2.33 3.07 3.09 3.09
STU:6XP
30GF Score
XSpray Pharma AB STU:6XP
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

XSpray Pharma AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 3.09% mean?
XSpray Pharma AB (STU:6XP) has a Institutional Ownership of 3.09% as of Aug. 25, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on XSpray Pharma AB and its competitors.
Is XSpray Pharma AB's Institutional Ownership too high?
XSpray Pharma AB's current Institutional Ownership is 3.09%. Overall, XSpray Pharma AB has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does XSpray Pharma AB's Institutional Ownership compare to VRTX and REGN?
XSpray Pharma AB's Institutional Ownership of 3.09% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on XSpray Pharma AB and its competitors. XSpray Pharma AB's current Institutional Ownership is 3.09%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XSpray Pharma AB stock overvalued right now?
XSpray Pharma AB (STU:6XP) has a current Institutional Ownership of 3.09%. The current Institutional Ownership is 3.09%. XSpray Pharma AB's overall GF Score™ is 30/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For XSpray Pharma AB (STU:6XP), the current Institutional Ownership is 3.09% as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

XSpray Pharma AB Business Description

Other Exchanges XSPRAY:Sweden0GHZ:UK
Address Scheeles vag 2, Solna, SWE, SE-171 65
XSpray Pharma AB is a pharmaceutical company focused on developing improved PKIs for cancer treatment, leveraging its proprietary HyNap technology platform. The company aims to enhance clinical outcomes for cancer patients by improving the efficacy, safety, and patient experience of existing cancer therapies. Its product portfolio includes Dasynoc and other product candidates in different stages of development such as XS003 nilotinib, XS008 axitinib, and other.
30GF Score

Get the complete analysis for STU:6XP

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.92
Price